
Larry Lei Xiao, Ph.D.
Co-Founder, Chairman, CEO & CSO
Over 20 years of experience in embryonic/induced pluripotent stem cells, cell therapy and gene editing.
Principal Investigator & Professor at Shanghai Institute of Biochemistry & Cell Biology and at Zhejiang University.
Postdoctorate at Johns Hopkins.
Ph.D. from Munich University, Germany.
US based.